PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALGN vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALGN and DXCM is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

ALGN vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Align Technology, Inc. (ALGN) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

2,000.00%2,500.00%3,000.00%3,500.00%NovemberDecember2025FebruaryMarchApril
2,298.59%
1,938.50%
ALGN
DXCM

Key characteristics

Sharpe Ratio

ALGN:

-1.34

DXCM:

-1.02

Sortino Ratio

ALGN:

-2.16

DXCM:

-1.30

Omega Ratio

ALGN:

0.76

DXCM:

0.76

Calmar Ratio

ALGN:

-0.64

DXCM:

-0.90

Martin Ratio

ALGN:

-1.59

DXCM:

-1.44

Ulcer Index

ALGN:

31.72%

DXCM:

39.49%

Daily Std Dev

ALGN:

37.62%

DXCM:

55.87%

Max Drawdown

ALGN:

-92.80%

DXCM:

-94.61%

Current Drawdown

ALGN:

-78.97%

DXCM:

-63.25%

Fundamentals

Market Cap

ALGN:

$11.30B

DXCM:

$23.46B

EPS

ALGN:

$5.62

DXCM:

$1.42

PE Ratio

ALGN:

27.31

DXCM:

42.13

PEG Ratio

ALGN:

1.04

DXCM:

0.98

Total Revenue (TTM)

ALGN:

$3.00B

DXCM:

$3.11B

Gross Profit (TTM)

ALGN:

$2.11B

DXCM:

$1.87B

EBITDA (TTM)

ALGN:

$633.28M

DXCM:

$724.50M

Returns By Period

In the year-to-date period, ALGN achieves a -26.38% return, which is significantly lower than DXCM's -23.07% return. Over the past 10 years, ALGN has underperformed DXCM with an annualized return of 11.34%, while DXCM has yielded a comparatively higher 14.27% annualized return.


ALGN

YTD

-26.38%

1M

-11.87%

6M

-36.40%

1Y

-51.26%

5Y*

-0.09%

10Y*

11.34%

DXCM

YTD

-23.07%

1M

-27.00%

6M

-12.16%

1Y

-55.13%

5Y*

-1.70%

10Y*

14.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALGN vs. DXCM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALGN
The Risk-Adjusted Performance Rank of ALGN is 77
Overall Rank
The Sharpe Ratio Rank of ALGN is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of ALGN is 33
Sortino Ratio Rank
The Omega Ratio Rank of ALGN is 55
Omega Ratio Rank
The Calmar Ratio Rank of ALGN is 1616
Calmar Ratio Rank
The Martin Ratio Rank of ALGN is 1010
Martin Ratio Rank

DXCM
The Risk-Adjusted Performance Rank of DXCM is 88
Overall Rank
The Sharpe Ratio Rank of DXCM is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 1111
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 55
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 44
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALGN vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALGN, currently valued at -1.34, compared to the broader market-2.00-1.000.001.002.00
ALGN: -1.34
DXCM: -1.02
The chart of Sortino ratio for ALGN, currently valued at -2.16, compared to the broader market-6.00-4.00-2.000.002.004.00
ALGN: -2.16
DXCM: -1.30
The chart of Omega ratio for ALGN, currently valued at 0.76, compared to the broader market0.501.001.502.00
ALGN: 0.76
DXCM: 0.76
The chart of Calmar ratio for ALGN, currently valued at -0.64, compared to the broader market0.001.002.003.004.00
ALGN: -0.64
DXCM: -0.90
The chart of Martin ratio for ALGN, currently valued at -1.59, compared to the broader market-10.000.0010.0020.00
ALGN: -1.59
DXCM: -1.44

The current ALGN Sharpe Ratio is -1.34, which is lower than the DXCM Sharpe Ratio of -1.02. The chart below compares the historical Sharpe Ratios of ALGN and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2025FebruaryMarchApril
-1.34
-1.02
ALGN
DXCM

Dividends

ALGN vs. DXCM - Dividend Comparison

Neither ALGN nor DXCM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALGN vs. DXCM - Drawdown Comparison

The maximum ALGN drawdown since its inception was -92.80%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for ALGN and DXCM. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%NovemberDecember2025FebruaryMarchApril
-78.97%
-63.25%
ALGN
DXCM

Volatility

ALGN vs. DXCM - Volatility Comparison

The current volatility for Align Technology, Inc. (ALGN) is 12.02%, while DexCom, Inc. (DXCM) has a volatility of 16.14%. This indicates that ALGN experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%NovemberDecember2025FebruaryMarchApril
12.02%
16.14%
ALGN
DXCM

Financials

ALGN vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between Align Technology, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab